Requested agent (plan members in Ohio) — Blue Cross Blue Shield of Texas
Any FDA labeled indication or compendia/peer-reviewed supported indication for the requested agent and route
Initial criteria
- Member resides in Ohio AND plan is Fully Insured or HIM Shop (SG) AND
- Patient has no FDA labeled contraindications to requested agent AND
- ONE of the following:
- • Patient has another FDA labeled indication for the agent and route OR
- • Indication supported in compendia (non-oncology: DrugDex level 1, 2A, 2B or AHFS-DI supportive text; oncology: NCCN 1 or 2A, AHFS-DI supportive text, DrugDex level 1, 2A, 2B, Clinical Pharmacology supportive, LexiDrugs evidence level A, or peer-reviewed literature) OR
- • Prescriber submitted TWO peer-reviewed journal articles (e.g., JAMA, NEJM, Lancet) supporting proposed use as safe/effective (case studies not accepted)
Reauthorization criteria
- Continued therapy requires that indication criteria remain met; no contraindications arise
Approval duration
12 months